Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,054 | -25,954 | -29,844 | -30,445 | -26,206 |
| Depreciation Amortization | 2,975 | 2,612 | 2,580 | 2,234 | 2,727 |
| Accounts receivable | 191 | -1,454 | 1,046 | 578 | -1,450 |
| Accounts payable and accrued liabilities | -1,093 | -80 | -574 | 1,043 | -455 |
| Other Working Capital | -3,313 | -400 | -771 | 1,656 | -1,449 |
| Other Operating Activity | -406 | 3,699 | 3,885 | 218 | 7,319 |
| Operating Cash Flow | $-19,700 | $-21,577 | $-23,678 | $-24,716 | $-19,514 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,190 | -3,779 | 14,445 | -19,719 | 10,097 |
| PPE Investments | -568 | -759 | -1,171 | -847 | -682 |
| Investing Cash Flow | $9,622 | $-4,538 | $13,274 | $-20,566 | $9,415 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 10,000 | N/A | N/A |
| Common Stock Issued | 5,623 | 8,449 | 28 | 30,066 | 20,706 |
| Other Financing Activity | -967 | 9,703 | -685 | 210 | -332 |
| Financing Cash Flow | $4,656 | $18,152 | $9,343 | $30,276 | $20,374 |
| Exchange Rate Effect | -49 | -245 | -2,284 | 1,102 | 1,206 |
| Beginning Cash Position | 20,772 | 28,980 | 32,325 | 46,229 | 34,748 |
| End Cash Position | 15,301 | 20,772 | 28,980 | 32,325 | 46,229 |
| Net Cash Flow | $-5,471 | $-8,208 | $-3,345 | $-13,904 | $11,481 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,700 | -21,577 | -23,678 | -24,716 | -19,514 |
| Capital Expenditure | -626 | -785 | -1,171 | -847 | -682 |
| Free Cash Flow | -20,326 | -22,362 | -24,849 | -25,563 | -20,196 |